Competitive Technologies: A Game Changer in Pain Management?
David Greene submits:Competitive Technologies (CTT) made a new 52-week high at $3.57 yesterday (May 13) on 5X average daily trading volume before doing an understandable retracement, which is continuing today at $2.90.Why the recent price appreciation coupled with increased liquidity? For one, there is much anticipation for the first comprehensive presentation of CTT's chronic pain management therapy device (named "Calmare"--Italian for "calm, soothe, pacify") to the medical community to be held this Monday, May 17. The inventor of Calmare, Professor Giuseppe Marineo, MD, DSc., Researcher, Founding President of Delta Research and Development, Tor Vergata University of Rome, Italy, is the keynote speaker at the Symposium for physicians. Dr. Marineo will present his "Scrambler Therapy," which interferes with pain signal transmission by ''mixing'' ''non-pain'' information into the nerve fibres. Other speakers include physicians from the Boston Foundation for Sight, the University of Miami, the University of Wisconsin, and Calmar Pain Relief, LLC, to present evidence-based patient case studies developed from the use of the Calmare system to treat various types of chronic pain from cancer and chemotherapy-induced peripheral neuropathy (CIPN), failed back surgery, phantom limb syndrome, sciatica, pain from shingles etc.. These case studies involved patients suffering from intractable pain after trying to get relief from other pain management treatments, such as painkillers. Patients that cannot use painkillers due to negative side effects were also included.Complete Story »